264 related articles for article (PubMed ID: 33360047)
41. Systematic review of metformin use in obese nondiabetic children and adolescents.
Brufani C; Crinò A; Fintini D; Patera PI; Cappa M; Manco M
Horm Res Paediatr; 2013; 80(2):78-85. PubMed ID: 23899569
[TBL] [Abstract][Full Text] [Related]
42. Metformin treatment to reduce central adiposity after prenatal growth restraint: a placebo-controlled pilot study in prepubertal children.
Díaz M; Bassols J; López-Bermejo A; de Zegher F; Ibáñez L
Pediatr Diabetes; 2015 Nov; 16(7):538-45. PubMed ID: 25332100
[TBL] [Abstract][Full Text] [Related]
43. Mixed Spices at Culinary Doses Have Prebiotic Effects in Healthy Adults: A Pilot Study.
Lu QY; Rasmussen AM; Yang J; Lee RP; Huang J; Shao P; Carpenter CL; Gilbuena I; Thames G; Henning SM; Heber D; Li Z
Nutrients; 2019 Jun; 11(6):. PubMed ID: 31242596
[TBL] [Abstract][Full Text] [Related]
44. Metformin in the treatment of obese children and adolescents at risk of type 2 diabetes.
Kendall DL; Amin R; Clayton PE
Paediatr Drugs; 2014 Feb; 16(1):13-20. PubMed ID: 23949947
[TBL] [Abstract][Full Text] [Related]
45. Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations.
Riva A; Borgo F; Lassandro C; Verduci E; Morace G; Borghi E; Berry D
Environ Microbiol; 2017 Jan; 19(1):95-105. PubMed ID: 27450202
[TBL] [Abstract][Full Text] [Related]
46. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
[TBL] [Abstract][Full Text] [Related]
47. Gut microbiota dysbiosis in stable coronary artery disease combined with type 2 diabetes mellitus influences cardiovascular prognosis.
Tian R; Liu H; Feng S; Wang H; Wang Y; Wang Y; Liang L; Xu H; Xing H; Zhang S
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1454-1466. PubMed ID: 33810955
[TBL] [Abstract][Full Text] [Related]
48. Reinforcement of intestinal epithelial barrier by arabinoxylans in overweight and obese subjects: A randomized controlled trial: Arabinoxylans in gut barrier.
Salden BN; Troost FJ; Wilms E; Truchado P; Vilchez-Vargas R; Pieper DH; Jáuregui R; Marzorati M; van de Wiele T; Possemiers S; Masclee AA
Clin Nutr; 2018 Apr; 37(2):471-480. PubMed ID: 28214040
[TBL] [Abstract][Full Text] [Related]
49. The Effect of Eighteen-Month Metformin Treatment in Obese Adolescents: Comparison of Results Obtained in Daily Practice with Results from a Clinical Trial.
van der Aa MP; Hoving V; van de Garde EM; de Boer A; Knibbe CA; van der Vorst MM
J Obes; 2016; 2016():7852648. PubMed ID: 28101379
[No Abstract] [Full Text] [Related]
50. Modulatory Effects of Triphala and Manjistha Dietary Supplementation on Human Gut Microbiota: A Double-Blind, Randomized, Placebo-Controlled Pilot Study.
Peterson CT; Pourang A; Dhaliwal S; Kohn JN; Uchitel S; Singh H; Mills PJ; Peterson SN; Sivamani RK
J Altern Complement Med; 2020 Nov; 26(11):1015-1024. PubMed ID: 32955913
[No Abstract] [Full Text] [Related]
51. Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study.
Wiegand S; l'Allemand D; Hübel H; Krude H; Bürmann M; Martus P; Grüters A; Holl RW
Eur J Endocrinol; 2010 Oct; 163(4):585-92. PubMed ID: 20639355
[TBL] [Abstract][Full Text] [Related]
52. Gut microbiome encoded purine and amino acid pathways present prospective biomarkers for predicting metformin therapy efficacy in newly diagnosed T2D patients.
Elbere I; Orlovskis Z; Ansone L; Silamikelis I; Jagare L; Birzniece L; Megnis K; Leskovskis K; Vaska A; Turks M; Klavins K; Pirags V; Briviba M; Klovins J
Gut Microbes; 2024; 16(1):2361491. PubMed ID: 38868903
[TBL] [Abstract][Full Text] [Related]
53. A randomized controlled trial of Mediterranean diet and metformin to prevent age-related diseases in people with metabolic syndrome.
Pasanisi P; Gargano G; Gaetana Di Mauro M; Cortellini M; Casagrande A; Villarini A; Bruno E; Roveda E; Saibene G; Venturelli E; Berrino F
Tumori; 2018; 104(2):137-142. PubMed ID: 28106245
[TBL] [Abstract][Full Text] [Related]
54. Childhood follow-up of the GRoW randomized trial: Metformin in addition to dietary and lifestyle advice for pregnant women with overweight or obesity.
Deussen AR; Louise J; Dodd JM
Pediatr Obes; 2023 Jan; 18(1):e12974. PubMed ID: 36093602
[TBL] [Abstract][Full Text] [Related]
55. Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus.
Syngelaki A; Nicolaides KH; Balani J; Hyer S; Akolekar R; Kotecha R; Pastides A; Shehata H
N Engl J Med; 2016 Feb; 374(5):434-43. PubMed ID: 26840133
[TBL] [Abstract][Full Text] [Related]
56. Therapeutic Effects of Butyrate on Pediatric Obesity: A Randomized Clinical Trial.
Coppola S; Nocerino R; Paparo L; Bedogni G; Calignano A; Di Scala C; de Giovanni di Santa Severina AF; De Filippis F; Ercolini D; Berni Canani R
JAMA Netw Open; 2022 Dec; 5(12):e2244912. PubMed ID: 36469320
[TBL] [Abstract][Full Text] [Related]
57. Use of Metformin for Weight Management in Children and Adolescents With Obesity in the Clinical Setting.
Kyler KE; Kadakia RB; Palac HL; Kwon S; Ariza AJ; Binns HJ
Clin Pediatr (Phila); 2018 Dec; 57(14):1677-1685. PubMed ID: 30261744
[TBL] [Abstract][Full Text] [Related]
58. Association of metformin administration with gut microbiome dysbiosis in healthy volunteers.
Elbere I; Kalnina I; Silamikelis I; Konrade I; Zaharenko L; Sekace K; Radovica-Spalvina I; Fridmanis D; Gudra D; Pirags V; Klovins J
PLoS One; 2018; 13(9):e0204317. PubMed ID: 30261008
[TBL] [Abstract][Full Text] [Related]
59. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial.
Løvvik TS; Carlsen SM; Salvesen Ø; Steffensen B; Bixo M; Gómez-Real F; Lønnebotn M; Hestvold KV; Zabielska R; Hirschberg AL; Trouva A; Thorarinsdottir S; Hjelle S; Berg AH; Andræ F; Poromaa IS; Mohlin J; Underdal M; Vanky E
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):256-266. PubMed ID: 30792154
[TBL] [Abstract][Full Text] [Related]
60. Metformin intervention in obese non-diabetic patients with breast cancer: phase II randomized, double-blind, placebo-controlled trial.
Ko KP; Ma SH; Yang JJ; Hwang Y; Ahn C; Cho YM; Noh DY; Park BJ; Han W; Park SK
Breast Cancer Res Treat; 2015 Sep; 153(2):361-70. PubMed ID: 26293146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
